iQ&A for Familial Hypercholesterolemia
iQ&A for SPAF Trials: UPDATE
iQ&A for Thrombosis Risk Reduction
iQ&A for Stroke Prevention in AF
iQ&A for Interventional Cardiology
iQ&A for STEMI Management
iQ&A for Cancer and Thrombosis
iQ&A for Thrombosis Management
iQ&A for DVT and PE
iQ&A for VTE Prophylaxis
iQ&A for Familial Hypercholesterolemia
iQ&A for SPAF Trials: UPDATE
iQ&A for Thrombosis Risk Reduction
iQ&A for Cancer and Thrombosis
iQ&A Stroke for Prevention in AF
iQ&A for VTE Prophylaxis
iQ&A for DVT and PE
iQ&A for Thrombosis Management
iQ&A for STEMI Management
iQ&A for Interventional Cardiology
iQ&A for Sepsis
iQ&A for Alzheimer’s Disease
iQ&A for SPAF Trials: UPDATE
iQ&A for Stroke Prevention in AF
iQ&A for Multiple Sclerosis
iQ&A for Adolescent Depression
iQ&A for Familial Hypercholesterolemia
iQ&A for Type 2 Diabetes
iQ&A for Rheumatoid Arthritis
iQ&A for Cancer and Thrombosis
iQ&A for Sepsis
iQ&A for Alzheimer’s Disease
iQ&A for Adolescent Depression
iQ&A for Familial Hypercholesterolemia
iQ&A for Alzheimer’s Disease
iQ&A for Type 2 Diabetes
iQ&A for Adolescent Depression
Play All
Speakers
Mary McGowan, MD
Michael Davidson, MD, FACC, FNLA
Professor Erik Stroes, MD
James De Lemos, MD
Prof. Heribert Schunkert, MD
William Boden, MD
Christie M. Ballantyne, MD
Paul Ridker, MD
Robin Choudhury, MD
Sotirios Tsimikas, MD, FACC, FAHA
Allen J. Taylor, MD, FACC, FAHA
Complete FAQ List
Resources
Mipomersen Lowers LDL in High-risk Statin-Intolerant Patients
NICE FH Quick Reference Guide
NCCPC Guidelines: Identification and Management of FH
Identifying and Treating FH
ENHANCE Trial
Ezetimibe for Hypercholesterolemia Management
Antisense inhibition of apoB synthesis with mipomersen
Mipomersen: Antisense Therapy Adjunct to Statins Hypercholesterolemia
Antisense therapy for the management of dyslipidemia
Antisense therapy in the treatment of hypercholesterolemia
Apolipoprotein B synthesis inhibition in mild-to-moderate hyperlipidaemia
NLA Symposium Screening and Treatment of FH
Apolipoprotein B synthesis Inhibition: Clinical Trials
Submit Questions
About iQ&A
CV Risk Reduction in Setting of Type 2 Diabetes
Stroke Prevention in AF
Metastatic Breast Cancer
Evolving Therapies in MS
Oral Therapy for Type 2 Diabetes
New Frontiers in Metastatic Breast Cancer
ClinicalWebcasts.com
OncologyCAST.net
CardioCAST.net
SepsisCAST.com
HypertensionCAST.com
NeuroPsychCAST.com
Updates in Alzheimer's Disease
Updates in Osteoporosis
Updates in Interventional Cardiology
Updates in Thrombosis
Updates in Parkinson's Disease
Updates in Depression
Landmark Advances in Cardiovascular Anesthesiology
Cancer and Thrombosis Management
Comprehensive Osteoporosis Management
MultipleSclerosisWRAP: Immunomodulation Therapy for Multiple Sclerosis
AntiplateletWRAP: Oral Antiplatelet Therapy and PPIs in ACS and CAD
Alzheimer’sWRAP: Foundation Role of Cholinergic Dysregulation in AD